#USA #Chicago #Sibel Health #Maruho #Samsung Next

Sibel Health Expands Its Financial Backing and Board Membership

On October 14, 2025, Sibel Health, a recognized leader in the digital health sector, announced the completion of an extension of its Series C financing round, achieving a remarkable total of $39 million. This funding round welcomed several significant investors, including Maruho Co., Ltd. and Samsung Next, building upon the initial Series C round that was already substantial, spearheaded earlier in the year by The Steele Foundation for Hope along with noteworthy contributions from Dräger.

The funds gathered from this extension are poised to enhance Sibel Health's capabilities, especially its advanced wearables, which seamlessly integrate with various mobile devices to provide continuous monitoring of vital signs. The company's platform hinges on clinical-grade technology coupled with artificial intelligence, allowing for timely alerts and comprehensive health tracking. CEO Dr. Steve Xu stated, “These new partners offer more than just financial capital; they contribute valuable expertise, scalability, and reach, which are essential for our healthcare innovations.”

One of Sibel’s strategic partners, Maruho Co., Ltd., specializes in the development of dermatological products in Asia and has been collaborating with Sibel Health on creating advanced digital health solutions tailored for dermatology. Akihiko Ikoma, a Senior Medical Director at Maruho, expressed enthusiasm about the partnership, emphasizing their intent to develop novel health solutions for skin conditions across the globe, starting with applications to alleviate itchiness.

Additionally, Sibel Health's core clinical monitoring platform, ANNE® One, utilizes Samsung mobile technologies for visualizing and alerting based on health waveforms, representing a shift in healthcare delivery that transcends traditional hospital settings. This notion was echoed by Jonathan Machado from Samsung Next, who highlighted the growth potential of combining Samsung’s innovative technology with Sibel’s medical wearables, potentially yielding an unparalleled offering for healthcare providers.

Beyond the financial injection, the announcement also included the appointment of key individuals to Sibel Health's board of directors as the company gears up for its next growth phase. Kimberly Querrey, who has been integral to the board since its inception in 2018, has been elected as Chairwoman, and Tim Sullivan, Vice Chair of Madison Dearborn Partners, joins as an independent board member, bringing a wealth of experience in health systems.

Dr. Xu emphasized that the collaborations with such industry leaders will be pivotal in transitioning from reactive to proactive health monitoring, thereby enhancing data collection for clinical trials and improving healthcare outcomes universally. With a capable team and strategic partnerships now solidified, Sibel Health is set to accelerate its mission of facilitating real-world health data integration into healthcare delivery and clinical research.

Sibel Health has made significant strides in providing effective health technology solutions with its FDA-cleared wearable sensors and software. They aim to make continuous health monitoring a standard practice, thus improving health management in a fast-evolving landscape. Based in Chicago and with an additional office in Seoul, Sibel Health is paving the way toward better health data accessibility for everyone, reinforcing its commitment to innovation in healthcare.

About Sibel Health

Sibel Health is dedicated to offering advanced solutions in the digital health arena. By focusing on delivering improved health data through their platforms, the company aspires to contribute to healthier living across the globe. For further information about their offerings, please navigate to Sibel Health's website.

About Maruho

Headquartered in Osaka, Maruho Co., Ltd. has established itself as a leader in dermatological product development, with an emphasis on patient wellbeing and innovative solutions since 1915.

About Samsung Next

Samsung Next is focused on investing in groundbreaking startups across various sectors, particularly in AI and health technology, reflecting their aim to drive forward-thinking innovations that improve lives.